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EditorialGenomics, Genetics, and Genes
of the Immune System
This special issue of Immunity is devoted to the impact the insights that can be gleaned from the use of DNA
microarray technology to profile gene expression in im-that genomic-scale technologies are having on our un-
derstanding of the immune system. It will become clear mune cells. They define a gene expression signature as
a group of genes that are coordinately expressed andto the reader of this issue that the line between genomics
and genetics is quite fuzzy. Indeed, it is possible to that are characteristic of a particular stage of cellular
differentiation or physiology. Gene expression signa-call researchers genomicists to be au courant, but the
underlying questions being addressed are the same as tures can be defined that indicate the activity of individ-
ual signaling proteins or transcription factors. Shafferhave been addressed by immunogeneticists for de-
cades. What is the relationship between genotype and et al. use gene expression signature analysis to suggest
that germinal center B cells are poised on the brink ofimmunological phenotype? Which genes cause or pre-
vent immunological diseases? How did the immune sys- apoptosis, as befits a cell undergoing negative selec-
tion, and that they favor cell division at the expensetem evolve? Genomics promises to address these ques-
tions comprehensively, by the use of a variety of high- of cell growth (size). In immunological diseases, gene
expression profiling can provide a comprehensive andthroughput technologies such as genomic sequencing,
DNA microarray gene expression profiling, ENU-based quantitative phenotype of the abnormal immune state.
Therefore, within a particular diagnostic category, genemouse mutagenesis, and whole-genome polymorphism
analysis. expression profiling can define subsets of patients that
have pathogenetically distinct variants of the disease.To understand immune function comprehensively,
we will ultimately need to generate a complete list of A true functional genomics technology, ENU muta-
genesis of the mouse, is described by Nelms and Good-proteins that function in immune cells. Conveniently and
probably by selection, evolution has clustered genes of now. This technology is able to introduce a loss of func-
tion mutation in any particular gene once in every 700immunological importance together in a few gene-dense
regions of the genome. While the tight genomic organi- gametes, and thus the progeny of these mutagenized
mice contain defects in multiple genes. Immunologicalzation of these immunologic loci has been a boon for
sequence analysis, it can confound genetic linkage anal- screens of these mice therefore test the immunological
roles of many individual genes in parallel, and cleverysis of immunological diseases, as discussed below.
The genomic structures of three key immunologic loci breeding schemes can bring multiple recessive muta-
tions to homozygosity in three generations. Initial resultsare reviewed in this issue: the major histocompatibility
complex (MHC), the T cell receptor (TCR) loci, and the predict a bright future for this technology: 25 lines of
mutant mice have been derived that have defects inNK receptor loci (NKC and LKR). Trowsdale focuses
on the intriguing functional interactions between MHC- lymphocyte subsets or function, and four lines develop
various cancers. The challenge of identifying the muta-encoded proteins and receptors for these proteins en-
coded in the NK receptor loci that modulate both innate tions molecularly can be met by backcrossing the mu-
tant lines to a genetically distinct mouse strain followedand acquired immunity. The high degree of polymor-
phism in MHC class I genes is matched by polymor- by linkage analysis of the immunological phenotype us-
ing polymorphic markers. The completion of the mousephisms in the KIR genes that encode receptors for class
I molecules on NK cells. Thus, as evolution has diversi- genome sequence will facilitate the identification of the
mutations based on sequencing of candidate genes infied the antigen presentation capabilities of class I mole-
cules, the NK receptors have had to keep pace with the appropriate chromosomal regions. To genetically
probe more subtle immunologic functions, ENU muta-this diversity. Interestingly, within the MHC and the NK
receptor loci reside a number of functionally uncharac- tion screens can start with sensitized strains that are
predisposed to autoimmune diseases or to cancer orterized genes that have a high probability of encoding
immunologically critical molecules based on their mem- that have well-characterized TCR or Ig transgenes that
focus attention on particular immune responses. Thisbership in these loci. Flajnik and Kasahara survey stud-
ies of MHC structure during phylogeny and argue that will enable the detection of genes which enhance or
suppress a given immune phenotype. This approachthis locus descended from an ancestral syntenic region
that contained genes regulating innate immunity. The has been most informative in genetic screens in inverte-
brates.present-day class I and II MHC genes presumably be-
came part of the MHC in jawed vertebrates, coincident Two reviews delve into the complex genetics of
autoimmune and inflammatory diseases. Genome-widewith the development of the adaptive immune system.
Glusman et al. present a comparative analysis of human linkage analysis and association studies have been used
to identify susceptibility and resistance loci in Type 1and mouse TCR genomic loci. They argue that all four
TCR loci evolved from a common rearranging locus that diabetes (T1D; Todd and Wicker) and in systemic lupus
erythematosis (SLE; Wakeland et al.). Polymorphisms inalso generated the immunoglobulin (Ig) loci, and that an
initial gene duplication event formed the precursors of the MHC contribute to both diseases, but the strong
linkage disequilibrium within the MHC makes it challeng-the TCR  and  loci, and, subsequently, each of these
loci were again duplicated. ing to implicate individual genes within this locus. None-
theless, Todd and Wicker describe studies suggestingOf course, the function of the immune system relies
not only on the structure of the immunologically impor- that certain MHC class II alleles protect individuals from
developing T1D. These alleles confer resistance to T1Dtant genes but also on their differential expression in
subsets of hematopoietic cells. Shaffer et al. describe even in the presence of susceptibility alleles of other
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genes. The authors develop the intriguing hypothesis these intervals. This data can be very helpful in focusing
that these alleles mediate tolerance to key self-antigens attention on certain candidate genes that are expressed
that have the potential to trigger an autoimmune re- in the cells of presumed functional importance. It is
sponse to pancreatic  cells. In this regard, certain al- highly likely that many of the disease susceptibility al-
leles of the insulin gene itself are also protective, and leles will not be structural mutations in protein coding
Todd and Wicker discuss the intriguing possibility that regions but rather will be regulatory mutations control-
these alleles may increase the expression of insulin ling mRNA abundance. DNA microarray analysis may
within the thymus, thereby promoting T cell tolerance be critical in identifying mutations that affect gene tran-
of insulin. Likewise, in SLE, Wakeland et al. suggest that scription, mRNA stability, or alternative splicing pat-
certain susceptibility loci control tolerance to nuclear terns. ENU mutagenesis screens could be performed in
antigens. strains containing autoimmunity loci, looking for new
In both T1D and SLE, though, a large number of mutations that complement the existing susceptibility
other genetic loci contribute to susceptibility and resis- loci. If obtained, such ENU-induced alleles should con-
tance that do not obviously control tolerance mecha- tain a single mutation in the interval of interest, thus
nisms. In both diseases, mouse models have been identifying the relevant gene and generating a new de-
instrumental in refining the genetic analysis since indi- fective allele in the process. Finally, it is conceivable that
vidual alleles can be rapidly isolated in congenic strains. genetic linkage analysis in human autoimmune diseases
Wakeland et al. review experiments suggesting that may be refined by using gene expression phenotypes
three susceptibility loci in mouse models of SLE control in addition to clinical phenotypes. For example, first-
three different immunological functions: tolerance to nu- degree relatives of SLE patients frequently have one or
clear antigens (Sle1), B cell activation (Sle2), and T cell a few SLE diagnostic signs or symptoms but do not
homeostasis (Sle3). Congenics with any one of these have the full-blown disease, suggesting that they harbor
susceptibility alleles do not develop clinical SLE, but one or more SLE susceptibility alleles. Perhaps gene
reassembly of these alleles from the congenics results expression profiling of the peripheral blood cells of these
in a strain that develops glomerulonephritis and suc- individuals would reveal a phenotype that is a manifesta-
cumbs to SLE. Analysis of the NOD model of T1D pre- tion of one of the susceptibility loci, and linkage analysis
sented by Todd and Wicker also demonstrates that the could be performed on this phenotype. However, lest it
disease phenotype is dictated by a complex interplay appear from this discussion that technologies alone will
of genes at 20 chromosomal loci. solve these complex disease puzzles, it is important to
Another theme that emerges from both autoimmu- emphasize that scientists with the greatest biological
nity reviews is the sharing of certain disease susceptibil- understanding are likely to see the most important clues
ity loci among different autoimmune diseases. The NOD that are hidden in the large datasets that emerge from
model of T1D also develops autoimmune thyroiditis and genomic-scale analyses.
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pathogenesis has been elusive in most cases. One of the
major impediments is the clustering of immunologically
important genes in the genome, as discussed above for
the MHC. In SLE, for example, an important susceptibil-
ity locus at chromosome 1q23 contains several tightly
linked immunoglobulin Fc receptor genes, any of which
might be functionally altered in the disease susceptibility
allele. Worse yet, fine mapping of a single susceptibility
locus for SLE in mice (Sle1) suggested that it contains
four separable susceptibility genes. Similar problems
have been encountered in TID.
Genomic technologies must come to the rescue.
First, we must develop a complete and accurate se-
quence of the genomic regions implicated in these dis-
eases, including identification of as many human (or
mouse) polymorphisms as possible in these loci. Fur-
ther, since alternative splicing of the mammalian ge-
nome is extensive, full-length cDNAs must be obtained
to delineate all splice variants expressed from these
loci. Second, DNA microarray technology can be used
to define the expression phenotype of each gene in
